Kavran AJ, Stuart SA, Hayashi KR, Basken JM, et al. Intermittent treatment of BRAF(V600E) melanoma cells delays resistance by adaptive resensitization to drug rechallenge. Proc Natl Acad Sci U S A 2022;119:e2113535119.
PMID: 35290123